Sorin has placed an order with Sphere Medical for cardiopulmonary bypass monitors and microanalyser consumables for delivery during the fourth quarter of 2012.
In 2008, the two companies signed a development and supply agreement in relation to the CPB product and this order represents the first sale for this product which will be used by Sorin in market assessment studies that are scheduled to commence later in 2012. CE marking of the CPB product is anticipated to coincide with the commencement of the market assessment studies. Completion of these studies is expected to lead to a European launch by Sorin of the CPB product, which is currently set for the first quarter of 2013. The first commercial sales of the CPB product are anticipated to coincide with the European launch.
The CPB product has been developed to enable the continuous blood monitoring of patients undergoing cardiopulmonary bypass surgery, where close monitoring of oxygenation and other blood parameters are required. Incorporating Sphereâs core microanalyser technology, the CPB product will allow the clinician to track a range of critical blood parameters in real time. This close monitoring will give clinicians an excellent assessment of a patientâs status and enable them to respond rapidly to a patientâs changing condition. This real time analysis is expected to contribute to improving clinical outcomes for cardiac surgery patients.